학술논문
Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial
Document Type
Article
Author
Lanzetta, P.; Korobelnik, J.-F.; Heier, J.S.; Leal, S.; Zhang, X.; Holz, F.G.; Clark, W.L.; Eichenbaum, D.; Iida, T.; Xiaodong, S.; Berliner, A.J.; Vitti, R.; Chu, K.W.; Reed, K.; Rao, R.; Bhore, R.; Cheng, Y.; Sun, W.; Hirshberg, B.; Yancopoulos, G.D.; Schulze, A.; Schmelter, T.; Schmidt-Ott, U.; Wong, T.Y.
Source
In: The Lancet . (The Lancet, 23 March 2024, 403(10432):1141-1152)
Subject
Language
English
ISSN
1474547X
01406736
01406736